chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Depression
Clinical narrative: anxiety; Depression; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (anxiety) and DEPRESSION (Depression) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer. Concomitant products included VENETOCLAX (VENCLEXTA) for Cancer.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced ANXIETY (anxiety) and DEPRESSION (Depression). The patient was treated with ALPRAZOLAM (XANAX) at an unspecified dose and frequency and ESCITALOPRAM OXALATE (LEXAPRO) at an unspecified dose and frequency. At the time of the report, ANXIETY (anxiety) and DEPRESSION (Depression) outcome was unknown.            Treatment for the events included alprazolam and escitalopram.   This case was linked to MOD-2021-109824 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Received first dose a month and half ago, still didn't get second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Received first dose a month and half ago, still didn't get second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Received first dose a month and half ago, still didn't get second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Received first dose a month and half ago, still didn't get second dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 28.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product dose omission issue
Clinical narrative: Expired vaccine used (Expiration: 01Jan2021); have not taken the second dose; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used (Expiration: 01Jan2021)) and PRODUCT DOSE OMISSION ISSUE (have not taken the second dose) in a 28-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN (MOTRIN [IBUPROFEN]) and PARACETAMOL (TYLENOL) for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used (Expiration: 01Jan2021)) and PRODUCT DOSE OMISSION ISSUE (have not taken the second dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used (Expiration: 01Jan2021)) and PRODUCT DOSE OMISSION ISSUE (have not taken the second dose) outcome was unknown. Not Provided    Treatment medication was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain, Poor quality product administered, Product storage error, Pyrexia
Clinical narrative: SLIGHT FEVER; patient received dose in right arm on 29 Apr2021 in morning and which was prefilled syringe outside from 26Apr2021 to 29Apr2021 in room temperature; patient received dose in right arm on 29 Apr2021 in morning and which was prefilled syringe outside from 26Apr2021 to 29Apr2021 in room temperature; Soreness; Headache; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (patient received dose in right arm on 29 Apr2021 in morning and which was prefilled syringe outside from 26Apr2021 to 29Apr2021 in room temperature), POOR QUALITY PRODUCT ADMINISTERED (patient received dose in right arm on 29 Apr2021 in morning and which was prefilled syringe outside from 26Apr2021 to 29Apr2021 in room temperature), PAIN (Soreness), HEADACHE (Headache) and PYREXIA (SLIGHT FEVER) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced PRODUCT STORAGE ERROR (patient received dose in right arm on 29 Apr2021 in morning and which was prefilled syringe outside from 26Apr2021 to 29Apr2021 in room temperature), POOR QUALITY PRODUCT ADMINISTERED (patient received dose in right arm on 29 Apr2021 in morning and which was prefilled syringe outside from 26Apr2021 to 29Apr2021 in room temperature), PAIN (Soreness) and HEADACHE (Headache). On an unknown date, the patient experienced PYREXIA (SLIGHT FEVER). At the time of the report, PRODUCT STORAGE ERROR (patient received dose in right arm on 29 Apr2021 in morning and which was prefilled syringe outside from 26Apr2021 to 29Apr2021 in room temperature) and POOR QUALITY PRODUCT ADMINISTERED (patient received dose in right arm on 29 Apr2021 in morning and which was prefilled syringe outside from 26Apr2021 to 29Apr2021 in room temperature) outcome was unknown and PAIN (Soreness), HEADACHE (Headache) and PYREXIA (SLIGHT FEVER) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment drugs were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-098155 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 13-Jun-2021: Follow up received on 13-Jun-2021. The events headache and soreness was reported.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-098155:
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Head discomfort, Nausea, Ocular hyperaemia
Clinical narrative: there's a pressure on head that is constant, hurt like she's going to throw up; eyes are like bloodshot, can't stay on devices; brain foggy, brain is not working properly, like has taken a bunch of Benadryl; hurt like she's going to throw up; exhausted from the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (there's a pressure on head that is constant, hurt like she's going to throw up), OCULAR HYPERAEMIA (eyes are like bloodshot, can't stay on devices), FEELING ABNORMAL (brain foggy, brain is not working properly, like has taken a bunch of Benadryl), NAUSEA (hurt like she's going to throw up) and FATIGUE (exhausted from the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in July 2020.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (there's a pressure on head that is constant, hurt like she's going to throw up), OCULAR HYPERAEMIA (eyes are like bloodshot, can't stay on devices), FEELING ABNORMAL (brain foggy, brain is not working properly, like has taken a bunch of Benadryl), NAUSEA (hurt like she's going to throw up) and FATIGUE (exhausted from the vaccine). At the time of the report, HEAD DISCOMFORT (there's a pressure on head that is constant, hurt like she's going to throw up), OCULAR HYPERAEMIA (eyes are like bloodshot, can't stay on devices), FEELING ABNORMAL (brain foggy, brain is not working properly, like has taken a bunch of Benadryl), NAUSEA (hurt like she's going to throw up) and FATIGUE (exhausted from the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment information was reported..   Reporter did not allow further contact
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Chills, Cough, Fatigue, Headache
Clinical narrative: Elevated blood sugar; Congestion; Cough; Fever of 100.4 degrees Fahrenheit; Chills; Headache; Achy all over; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Elevated blood sugar), NASAL CONGESTION (Congestion), COUGH (Cough), PYREXIA (Fever of 100.4 degrees Fahrenheit) and CHILLS (Chills) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Coronavirus infection in May 2020.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced BLOOD GLUCOSE INCREASED (Elevated blood sugar), NASAL CONGESTION (Congestion), COUGH (Cough), PYREXIA (Fever of 100.4 degrees Fahrenheit), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Achy all over) and FATIGUE (Fatigue). At the time of the report, BLOOD GLUCOSE INCREASED (Elevated blood sugar), NASAL CONGESTION (Congestion), COUGH (Cough), PYREXIA (Fever of 100.4 degrees Fahrenheit), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Achy all over) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medication reported includes Tylenol.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nasal congestion, Pyrexia
Clinical narrative: Elevated blood sugar; Congestion; Cough; Fever of 100.4 degrees Fahrenheit; Chills; Headache; Achy all over; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Elevated blood sugar), NASAL CONGESTION (Congestion), COUGH (Cough), PYREXIA (Fever of 100.4 degrees Fahrenheit) and CHILLS (Chills) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Coronavirus infection in May 2020.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced BLOOD GLUCOSE INCREASED (Elevated blood sugar), NASAL CONGESTION (Congestion), COUGH (Cough), PYREXIA (Fever of 100.4 degrees Fahrenheit), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Achy all over) and FATIGUE (Fatigue). At the time of the report, BLOOD GLUCOSE INCREASED (Elevated blood sugar), NASAL CONGESTION (Congestion), COUGH (Cough), PYREXIA (Fever of 100.4 degrees Fahrenheit), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Achy all over) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medication reported includes Tylenol.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and PYREXIA (fever). At the time of the report, CHILLS (chills) and PYREXIA (fever) outcome was unknown. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and PYREXIA (fever). At the time of the report, CHILLS (chills) and PYREXIA (fever) outcome was unknown.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old was accidentally vaccinated; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old was accidentally vaccinated) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concomitant products included MEDROXYPROGESTERONE ACETATE (DEPO-PROVERA), FLUTICASONE PROPIONATE (FLOVENT), SODIUM CHLORIDE (SALINE NASAL SPRAY), MONTELUKAST, Minerin cream, Albuterol inhaler                                              As needed and GUANFACINE for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old was accidentally vaccinated). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old was accidentally vaccinated) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Headache, Joint swelling
Clinical narrative: Chills; Fatigue; Nausea; Headache; Swelling of left arm; redness and soreness at injection site; soreness at injection site; Swelling extending to neck and left collar bone; swelling warm to touch; soreness sensitivity heat in upper arm and chest area and neck area; sensitivity heat in upper arm and chest area and neck area; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache) and PERIPHERAL SWELLING (Swelling of left arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache), PERIPHERAL SWELLING (Swelling of left arm), ERYTHEMA (redness and soreness at injection site), VACCINATION SITE PAIN (soreness at injection site), JOINT SWELLING (Swelling extending to neck and left collar bone), SKIN WARM (swelling warm to touch), MYALGIA (soreness sensitivity heat in upper arm and chest area and neck area) and TEMPERATURE INTOLERANCE (sensitivity heat in upper arm and chest area and neck area). At the time of the report, CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache), PERIPHERAL SWELLING (Swelling of left arm), ERYTHEMA (redness and soreness at injection site), VACCINATION SITE PAIN (soreness at injection site), JOINT SWELLING (Swelling extending to neck and left collar bone), SKIN WARM (swelling warm to touch), MYALGIA (soreness sensitivity heat in upper arm and chest area and neck area) and TEMPERATURE INTOLERANCE (sensitivity heat in upper arm and chest area and neck area) outcome was unknown. Not Provided
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Peripheral swelling, Skin warm, Temperature intolerance
Clinical narrative: Chills; Fatigue; Nausea; Headache; Swelling of left arm; redness and soreness at injection site; soreness at injection site; Swelling extending to neck and left collar bone; swelling warm to touch; soreness sensitivity heat in upper arm and chest area and neck area; sensitivity heat in upper arm and chest area and neck area; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache) and PERIPHERAL SWELLING (Swelling of left arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache), PERIPHERAL SWELLING (Swelling of left arm), ERYTHEMA (redness and soreness at injection site), VACCINATION SITE PAIN (soreness at injection site), JOINT SWELLING (Swelling extending to neck and left collar bone), SKIN WARM (swelling warm to touch), MYALGIA (soreness sensitivity heat in upper arm and chest area and neck area) and TEMPERATURE INTOLERANCE (sensitivity heat in upper arm and chest area and neck area). At the time of the report, CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache), PERIPHERAL SWELLING (Swelling of left arm), ERYTHEMA (redness and soreness at injection site), VACCINATION SITE PAIN (soreness at injection site), JOINT SWELLING (Swelling extending to neck and left collar bone), SKIN WARM (swelling warm to touch), MYALGIA (soreness sensitivity heat in upper arm and chest area and neck area) and TEMPERATURE INTOLERANCE (sensitivity heat in upper arm and chest area and neck area) outcome was unknown. Not Provided
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Chills; Fatigue; Nausea; Headache; Swelling of left arm; redness and soreness at injection site; soreness at injection site; Swelling extending to neck and left collar bone; swelling warm to touch; soreness sensitivity heat in upper arm and chest area and neck area; sensitivity heat in upper arm and chest area and neck area; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache) and PERIPHERAL SWELLING (Swelling of left arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache), PERIPHERAL SWELLING (Swelling of left arm), ERYTHEMA (redness and soreness at injection site), VACCINATION SITE PAIN (soreness at injection site), JOINT SWELLING (Swelling extending to neck and left collar bone), SKIN WARM (swelling warm to touch), MYALGIA (soreness sensitivity heat in upper arm and chest area and neck area) and TEMPERATURE INTOLERANCE (sensitivity heat in upper arm and chest area and neck area). At the time of the report, CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea), HEADACHE (Headache), PERIPHERAL SWELLING (Swelling of left arm), ERYTHEMA (redness and soreness at injection site), VACCINATION SITE PAIN (soreness at injection site), JOINT SWELLING (Swelling extending to neck and left collar bone), SKIN WARM (swelling warm to touch), MYALGIA (soreness sensitivity heat in upper arm and chest area and neck area) and TEMPERATURE INTOLERANCE (sensitivity heat in upper arm and chest area and neck area) outcome was unknown. Not Provided
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives on both upper arms after 1st dose; Arms itching like crazy after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives on both upper arms after 1st dose) and PRURITUS (Arms itching like crazy after 1st dose) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives on both upper arms after 1st dose) and PRURITUS (Arms itching like crazy after 1st dose). At the time of the report, URTICARIA (Hives on both upper arms after 1st dose) and PRURITUS (Arms itching like crazy after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  No concomitant and treatment details were provided.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Bedridden, Facial pain, Fatigue
Clinical narrative: Face hurt; couldn't get out of bed; extreme Fatigue; completely drained of energy, had to force myself to get out of bed to go the bathroom; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (completely drained of energy, had to force myself to get out of bed to go the bathroom), FACIAL PAIN (Face hurt), BEDRIDDEN (couldn't get out of bed) and FATIGUE (extreme Fatigue) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 03-Apr-2021, the patient experienced ASTHENIA (completely drained of energy, had to force myself to get out of bed to go the bathroom). On 03-May-2021, the patient experienced FACIAL PAIN (Face hurt), BEDRIDDEN (couldn't get out of bed) and FATIGUE (extreme Fatigue). On 05-Apr-2021, ASTHENIA (completely drained of energy, had to force myself to get out of bed to go the bathroom) outcome was unknown. At the time of the report, FACIAL PAIN (Face hurt), BEDRIDDEN (couldn't get out of bed) and FATIGUE (extreme Fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itchy; Rash all over his body; This spontaneous case was reported by a nurse and describes the occurrence of PRURITUS (Itchy) and RASH (Rash all over his body) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported. No concomitant medication was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced PRURITUS (Itchy) and RASH (Rash all over his body). At the time of the report, PRURITUS (Itchy) and RASH (Rash all over his body) outcome was unknown.      Treatment medication included Topical Lotions.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced FATIGUE (Tiredness). At the time of the report, FATIGUE (Tiredness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. The reporter stated that the patient took a nap, got up and was fine. No treatment was provided.   This case was linked to MOD21-087572, US-MODERNATX, INC.-MOD-2021-110137 (E2B Linked Report).; Sender's Comments:  MOD21-087572:Wife case US-MODERNATX, INC.-MOD-2021-110137:Wife case
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Vaccination site movement impairment
Clinical narrative: painful arm; vaccination site movement impairment; Strange headache on the left side of head; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (painful arm), VACCINATION SITE MOVEMENT IMPAIRMENT (vaccination site movement impairment) and HEADACHE (Strange headache on the left side of head) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced PAIN IN EXTREMITY (painful arm) and VACCINATION SITE MOVEMENT IMPAIRMENT (vaccination site movement impairment). 06-May-2021, the patient experienced HEADACHE (Strange headache on the left side of head). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (painful arm) and VACCINATION SITE MOVEMENT IMPAIRMENT (vaccination site movement impairment) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant drugs were not reported
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: injection after 42 days; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (injection after 42 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (injection after 42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (injection after 42 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment drugs were reported. Consent to follow up was not obtained before the line was disconnected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dizziness, Myalgia, Pyrexia
Clinical narrative: cough,; dizziness.; arm soreness; fever; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough,), DIZZINESS (dizziness.), MYALGIA (arm soreness) and PYREXIA (fever) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced COUGH (cough), DIZZINESS (dizziness), MYALGIA (arm soreness) and PYREXIA (fever). At the time of the report, COUGH (cough), DIZZINESS (dizziness.), MYALGIA (arm soreness) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided Treatment medication include Vitamins, Vitamin C, allergy medicine, Fish oil, Zinc, Aspirin, Advil .
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Insomnia, Peripheral swelling
Clinical narrative: swelling of ring finger in the left hand; swelling in left leg; difficulty sleeping; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling of ring finger in the left hand), PERIPHERAL SWELLING (swelling in left leg), INSOMNIA (difficulty sleeping) and ARTHRALGIA (Joint pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling of ring finger in the left hand), PERIPHERAL SWELLING (swelling in left leg), INSOMNIA (difficulty sleeping) and ARTHRALGIA (Joint pain). At the time of the report, PERIPHERAL SWELLING (swelling of ring finger in the left hand), PERIPHERAL SWELLING (swelling in left leg), INSOMNIA (difficulty sleeping) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Eye irritation, Fatigue, Lacrimation increased
Clinical narrative: itching; redness; rash; body fatigue; aching in her left shoulder; sore throat; burning and watery eyes; burning and watery eyes; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), EYE IRRITATION (burning and watery eyes), LACRIMATION INCREASED (burning and watery eyes), PRURITUS (itching) and ERYTHEMA (redness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), EYE IRRITATION (burning and watery eyes) and LACRIMATION INCREASED (burning and watery eyes). On an unknown date, the patient experienced PRURITUS (itching), ERYTHEMA (redness), RASH (rash), FATIGUE (body fatigue) and ARTHRALGIA (aching in her left shoulder). At the time of the report, OROPHARYNGEAL PAIN (sore throat), EYE IRRITATION (burning and watery eyes), LACRIMATION INCREASED (burning and watery eyes), PRURITUS (itching), ERYTHEMA (redness), RASH (rash), FATIGUE (body fatigue) and ARTHRALGIA (aching in her left shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment :aspirin, loratadine and  Cera Ve
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pruritus, Rash
Clinical narrative: itching; redness; rash; body fatigue; aching in her left shoulder; sore throat; burning and watery eyes; burning and watery eyes; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), EYE IRRITATION (burning and watery eyes), LACRIMATION INCREASED (burning and watery eyes), PRURITUS (itching) and ERYTHEMA (redness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), EYE IRRITATION (burning and watery eyes) and LACRIMATION INCREASED (burning and watery eyes). On an unknown date, the patient experienced PRURITUS (itching), ERYTHEMA (redness), RASH (rash), FATIGUE (body fatigue) and ARTHRALGIA (aching in her left shoulder). At the time of the report, OROPHARYNGEAL PAIN (sore throat), EYE IRRITATION (burning and watery eyes), LACRIMATION INCREASED (burning and watery eyes), PRURITUS (itching), ERYTHEMA (redness), RASH (rash), FATIGUE (body fatigue) and ARTHRALGIA (aching in her left shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment :aspirin, loratadine and  Cera Ve
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dizziness, Pyrexia, Vaccination site pain
Clinical narrative: vaccination site pain; Dizziness; Fever; cough; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain), COUGH (cough), DIZZINESS (Dizziness) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced COUGH (cough) and PYREXIA (Fever). On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site pain) and DIZZINESS (Dizziness). At the time of the report, VACCINATION SITE PAIN (vaccination site pain), COUGH (cough), DIZZINESS (Dizziness) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medication were not provided   This case was linked to MODERNATX, INC.-MOD-2021-109993 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2021-109993:Wife case
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: missed second dose of Moderna COVID-19 vaccine / to get it rescheduled; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed second dose of Moderna COVID-19 vaccine / to get it rescheduled) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed second dose of Moderna COVID-19 vaccine / to get it rescheduled). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed second dose of Moderna COVID-19 vaccine / to get it rescheduled) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  Treatment details were not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Feeling abnormal, Limb injury, Vaccination site pain
Clinical narrative: tripped on a mat & hit her shoulder on the corner of a wooden shelf; It might be a heart problem; having pain near my underarm; having pain underneath my shoulder; having pain left upper back; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (having pain left upper back), LIMB INJURY (tripped on a mat & hit her shoulder on the corner of a wooden shelf), FEELING ABNORMAL (It might be a heart problem), VACCINATION SITE PAIN (having pain near my underarm) and ARTHRALGIA (having pain underneath my shoulder) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-1961, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 02-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced BACK PAIN (having pain left upper back), VACCINATION SITE PAIN (having pain near my underarm) and ARTHRALGIA (having pain underneath my shoulder). On 06-May-2021, the patient experienced FEELING ABNORMAL (It might be a heart problem). On an unknown date, the patient experienced LIMB INJURY (tripped on a mat & hit her shoulder on the corner of a wooden shelf). At the time of the report, BACK PAIN (having pain left upper back), LIMB INJURY (tripped on a mat & hit her shoulder on the corner of a wooden shelf), FEELING ABNORMAL (It might be a heart problem), VACCINATION SITE PAIN (having pain near my underarm) and ARTHRALGIA (having pain underneath my shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment provided was ice,Aspirin. concomitant drugs were not provided   This case was linked to MOD-2021-110381 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced MALAISE (not feeling well). At the time of the report, MALAISE (not feeling well) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow up TCR report received included no new information.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: worsened swollen groin lymph nodes; swollen groin lymph nodes; swollen neck lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen neck lymph nodes), LYMPHADENOPATHY (swollen groin lymph nodes) and LYMPHADENOPATHY (worsened swollen groin lymph nodes) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No medical history provided by the reporter.     On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On 01-May-2021, the patient experienced LYMPHADENOPATHY (swollen neck lymph nodes). On 04-May-2021, the patient experienced LYMPHADENOPATHY (swollen groin lymph nodes). On 06-May-2021, the patient experienced LYMPHADENOPATHY (worsened swollen groin lymph nodes). At the time of the report, LYMPHADENOPATHY (swollen neck lymph nodes), LYMPHADENOPATHY (swollen groin lymph nodes) and LYMPHADENOPATHY (worsened swollen groin lymph nodes) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment include Ibuprofen. No other medication reported. the patient race identified.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Vomiting
Clinical narrative: heart beat has been really beating fast; throwing up; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heart beat has been really beating fast) and VOMITING (throwing up) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     no medical history reported.     On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (heart beat has been really beating fast) and VOMITING (throwing up). At the time of the report, HEART RATE INCREASED (heart beat has been really beating fast) and VOMITING (throwing up) outcome was unknown. Not Provided
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Hot flush, Hyperhidrosis, Nasopharyngitis, Product dose omission issue
Clinical narrative: She has not taken the second vaccine; last episode of hot flashes "about a month ago"; She gets cold; she gets hot; Sweating; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (She gets cold), FEELING HOT (she gets hot), HYPERHIDROSIS (Sweating), PRODUCT DOSE OMISSION ISSUE (She has not taken the second vaccine) and HOT FLUSH (last episode of hot flashes "about a month ago") in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Tremor. Concomitant products included TRAMADOL, PRIMIDONE, PROPRANOLOL, LOSARTAN, TRIAMTERENE and PREDNISONE for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced NASOPHARYNGITIS (She gets cold), FEELING HOT (she gets hot) and HYPERHIDROSIS (Sweating). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (She has not taken the second vaccine) and HOT FLUSH (last episode of hot flashes "about a month ago"). At the time of the report, NASOPHARYNGITIS (She gets cold), FEELING HOT (she gets hot), HYPERHIDROSIS (Sweating) and PRODUCT DOSE OMISSION ISSUE (She has not taken the second vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that she was allergic to lot of medications. Treatment for the events were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Additional events added
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Joint swelling
Clinical narrative: Swelling on ankle; Redness on ankle; Pain on ankle; This spontaneous case was reported by an other health care professional and describes the occurrence of JOINT SWELLING (Swelling on ankle), ERYTHEMA (Redness on ankle) and ARTHRALGIA (Pain on ankle) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     Concurrent medical conditions included Gout.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced JOINT SWELLING (Swelling on ankle), ERYTHEMA (Redness on ankle) and ARTHRALGIA (Pain on ankle). At the time of the report, JOINT SWELLING (Swelling on ankle), ERYTHEMA (Redness on ankle) and ARTHRALGIA (Pain on ankle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness
Clinical narrative: flu like symptoms; felling more tired than usual; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) and FATIGUE (felling more tired than usual) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and FATIGUE (felling more tired than usual). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  No concomitant and treatment details were provided.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: swollen face around the left side of her lip; This spontaneous case was reported by a pharmacist and describes the occurrence of SWELLING FACE (swollen face around the left side of her lip) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (swollen face around the left side of her lip).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Feeling druggy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling druggy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feeling druggy). At the time of the report, FEELING ABNORMAL (Feeling druggy) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. No Relevant concomitant medications was reported. Treatment information was not provided.